Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

177 Views

A2. PK/PD studies

Poster Session: PK/PD Studies

(P-1231) A Phase 1 Open-label, Parallel-group, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Obeldesivir in Participants with Normal Renal Function and Renal Impairment

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

Elham Amini, PharmD, PhD (she/her/hers)

Clinical Pharmacologist
Gilead Sciences, Inc.
Foster City, CA, United States

Co-Author(s)

YK

Yiannis Koullias, MD

Gilead Sciences, Inc.
Foster City, California, United States
SM

Sharline Madera, MD, PhD

Gilead Sciences, Inc.
Foster City, California, United States
NN

NgocQuyen Nguyen, PharmD

Gilead Sciences, Inc.
Foster City, California, United States
SW

Steve West, MSPH

Gilead Sciences, Inc., Foster City, CA, USA
Foster City, California, United States
HW

Helen Winter, PhD

Gilead Sciences, Inc.
Foster City, California, United States
LC

Luzelena Caro, PhD

Gilead Sciences, Inc.
Foster City, California, United States